18F-FDG PET radiomic analysis to predict outcomes in metastatic melanoma treated with immune checkpoint inhibitors

20260 citationsJournal Articlegold Open Access

Authors

Karim Amrane · Inserm

Coline Le Meur · Centre Hospitalier Régional Universitaire de Brest

David Bourhis · Inserm

Christian Berthou · Inserm

Olivier Pradier · Inserm

Laurent Misery · Centre Hospitalier Régional Universitaire de Brest

Délphine Legoupil ·

Abstract

The MEL-RAD radiomic model based on pre-treatment FDG-PET/CT offers a non-invasive biomarker to stratify metastatic CM patients treated with immunotherapy.

Topics & Keywords

Radiomics and Machine Learning in Medical Imaging Cancer Immunotherapy and Biomarkers Cutaneous Melanoma Detection and Management

Publication Details

Published in: Frontiers in Immunology

Volume 17, pp. 1642620-1642620

DOI: 10.3389/fimmu.2026.1642620

Field-Weighted Citation Impact: 0.00

Command Palette

18F-FDG PET radiomic analysis to predict outcomes in metastatic melanoma treated with immune checkpoint inhibitors

Authors

Abstract

Topics & Keywords

Publication Details